Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - קפסולות - ziprasidone as hydrochloride monohydrate 60 mg - ziprasidone - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - קפסולות - ziprasidone as hydrochloride monohydrate 80 mg - ziprasidone - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - קפסולות - ziprasidone as hydrochloride monohydrate 20 mg - ziprasidone - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone mesylate trihydrate - אבקה להכנת תמיסה לזריקה - ziprasidone mesylate trihydrate 40.93 mg - ziprasidone - ziprasidone - rapid control of agitation in patients with schizophrenia, when oral therapy is not appropriate, for a maximum of 3 consecutive days.

Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - טבליות עם שחרור מושהה - alprazolam 0.5 mg - alprazolam - alprazolam - for the management of anxiety and anxiety associated with depression.treatment of panic disorder with or without phobic avoidance

Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - טבליות עם שחרור מושהה - alprazolam 1 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance

Izraēla - ivrits - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - טבליות עם שחרור מושהה - alprazolam 2 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression. treatment of panic disorder with or without phobic avoidance

Izraēla - ivrits - Ministry of Health

teva pharmaceutical industries ltd, israel - flunitrazepam - טבליה - flunitrazepam 2 mg - flunitrazepam - flunitrazepam - insomnia of various etiology.

Izraēla - ivrits - Ministry of Health

teva pharmaceutical industries ltd, israel - mirtazapine - טבליה - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

Izraēla - ivrits - Ministry of Health

teva pharmaceutical industries ltd, israel - mirtazapine - טבליה - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.